143 related articles for article (PubMed ID: 30069819)
1. DUSP3/VHR: A Druggable Dual Phosphatase for Human Diseases.
Monteiro LF; Ferruzo PYM; Russo LC; Farias JO; Forti FL
Rev Physiol Biochem Pharmacol; 2019; 176():1-35. PubMed ID: 30069819
[TBL] [Abstract][Full Text] [Related]
2. Revisiting the roles of VHR/DUSP3 phosphatase in human diseases.
Russo LC; Farias JO; Ferruzo PYM; Monteiro LF; Forti FL
Clinics (Sao Paulo); 2018 Sep; 73(suppl 1):e466s. PubMed ID: 30208163
[TBL] [Abstract][Full Text] [Related]
3. VHR/DUSP3 phosphatase: structure, function and regulation.
Pavic K; Duan G; Köhn M
FEBS J; 2015 May; 282(10):1871-90. PubMed ID: 25757426
[TBL] [Abstract][Full Text] [Related]
4. Loss of DUSP3 activity radiosensitizes human tumor cell lines via attenuation of DNA repair pathways.
Torres TEP; Russo LC; Santos A; Marques GR; Magalhaes YT; Tabassum S; Forti FL
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1879-1894. PubMed ID: 28389334
[TBL] [Abstract][Full Text] [Related]
5. DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase.
Amand M; Erpicum C; Bajou K; Cerignoli F; Blacher S; Martin M; Dequiedt F; Drion P; Singh P; Zurashvili T; Vandereyken M; Musumeci L; Mustelin T; Moutschen M; Gilles C; Noel A; Rahmouni S
Mol Cancer; 2014 May; 13():108. PubMed ID: 24886454
[TBL] [Abstract][Full Text] [Related]
6. Combined experimental and bioinformatics analysis for the prediction and identification of VHR/DUSP3 nuclear targets related to DNA damage and repair.
Forti FL
Integr Biol (Camb); 2015 Jan; 7(1):73-89. PubMed ID: 25375676
[TBL] [Abstract][Full Text] [Related]
7. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
Arnoldussen YJ; Lorenzo PI; Pretorius ME; Waehre H; Risberg B; Maelandsmo GM; Danielsen HE; Saatcioglu F
Cancer Res; 2008 Nov; 68(22):9255-64. PubMed ID: 19010898
[TBL] [Abstract][Full Text] [Related]
8. Reduced levels of Dusp3/Vhr phosphatase impair normal spindle bipolarity in an Erk1/2 activity-dependent manner.
Tambe MB; Narvi E; Kallio M
FEBS Lett; 2016 Aug; 590(16):2757-67. PubMed ID: 27423135
[TBL] [Abstract][Full Text] [Related]
9. The role of dual-specificity phosphatase 3 in melanocytic oncogenesis.
Chousakos E; Katsoulas N; Kavantzas N; Stratigos A; Lazaris AC
Exp Dermatol; 2022 Oct; 31(10):1466-1476. PubMed ID: 35899430
[TBL] [Abstract][Full Text] [Related]
10. Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase (JNK).
Todd JL; Rigas JD; Rafty LA; Denu JM
Oncogene; 2002 Apr; 21(16):2573-83. PubMed ID: 11971192
[TBL] [Abstract][Full Text] [Related]
11. Proteomic, cellular, and network analyses reveal new DUSP3 interactions with nucleolar proteins in HeLa cells.
Panico K; Forti FL
J Proteome Res; 2013 Dec; 12(12):5851-66. PubMed ID: 24245651
[TBL] [Abstract][Full Text] [Related]
12. Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway.
Todd JL; Tanner KG; Denu JM
J Biol Chem; 1999 May; 274(19):13271-80. PubMed ID: 10224087
[TBL] [Abstract][Full Text] [Related]
13. UV Radiation-induced Impairment of Cellular Morphology and Motility is Enhanced by DUSP3/VHR Loss and FAK Activation.
Pereira NR; Russo LC; Forti FL
Cell Biochem Biophys; 2021 Jun; 79(2):261-269. PubMed ID: 33479884
[TBL] [Abstract][Full Text] [Related]
14. Deficiency in VHR/DUSP3, a suppressor of focal adhesion kinase, reveals its role in regulating cell adhesion and migration.
Chen YR; Chou HC; Yang CH; Chen HY; Liu YW; Lin TY; Yeh CL; Chao WT; Tsou HH; Chuang HC; Tan TH
Oncogene; 2017 Nov; 36(47):6509-6517. PubMed ID: 28759036
[TBL] [Abstract][Full Text] [Related]
15. The Dual-specificity Phosphatase 3 (DUSP3): A Potential Target Against Renal Ischemia/Reperfusion Injury.
Khbouz B; Musumeci L; Grahammer F; Jouret F
Transplantation; 2024 Apr; ():. PubMed ID: 38587920
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of VHR phosphatase by ZAP-70.
Alonso A; Rahmouni S; Williams S; van Stipdonk M; Jaroszewski L; Godzik A; Abraham RT; Schoenberger SP; Mustelin T
Nat Immunol; 2003 Jan; 4(1):44-8. PubMed ID: 12447358
[TBL] [Abstract][Full Text] [Related]
17. DUSP3 regulates phosphorylation-mediated degradation of occludin and is required for maintaining epithelial tight junction.
Chou HC; Cheng CM; Yang CH; Lin TY; Liu YW; Tan TH; Chen YR
J Biomed Sci; 2022 Jun; 29(1):40. PubMed ID: 35705979
[TBL] [Abstract][Full Text] [Related]
18. Dual-specificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis.
Musumeci L; Kuijpers MJ; Gilio K; Hego A; Théâtre E; Maurissen L; Vandereyken M; Diogo CV; Lecut C; Guilmain W; Bobkova EV; Eble JA; Dahl R; Drion P; Rascon J; Mostofi Y; Yuan H; Sergienko E; Chung TD; Thiry M; Senis Y; Moutschen M; Mustelin T; Lancellotti P; Heemskerk JW; Tautz L; Oury C; Rahmouni S
Circulation; 2015 Feb; 131(7):656-68. PubMed ID: 25520375
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR).
Alonso A; Merlo JJ; Na S; Kholod N; Jaroszewski L; Kharitonenkov A; Williams S; Godzik A; Posada JD; Mustelin T
J Biol Chem; 2002 Feb; 277(7):5524-8. PubMed ID: 11733513
[TBL] [Abstract][Full Text] [Related]
20. Phosphotyrosine Substrate Sequence Motifs for Dual Specificity Phosphatases.
Zhao BM; Keasey SL; Tropea JE; Lountos GT; Dyas BK; Cherry S; Raran-Kurussi S; Waugh DS; Ulrich RG
PLoS One; 2015; 10(8):e0134984. PubMed ID: 26302245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
